{
  "id": 3218,
  "text": "A., et al.A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: A., et al.A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "在研究中比较两个不同的新辅助化疗方案（TIP 和 TP）对局部晚期鳞状细胞宫颈癌患者术后效果，通常采用随机对照试验的方法。具体而言，可以设立两个患者组，其中一个组接受三药联合方案（紫杉醇、异环膦酰胺和顺铂，即TIP方案），另一个组接受双药联合方案（紫杉醇和顺铂，即TP方案）。两组患者在接受化疗后，均进行根治性手术。通过对比两个组患者在手术后的疗效，例如病灶的缩小程度、病理完全缓解率、术后并发症发生率、生存率及无疾病进展时间等指标，可以评估两种方案相对的临床效果。这样的设计能够有效比较TIP和TP方案对局部晚期鳞状细胞宫颈癌术后效果的差异。",
  "query": "研究中两个不同的新辅助化疗方案（TIP 和 TP）对局部晚期鳞状细胞宫颈癌患者术后效果的比较方法是什么？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 研究中两个不同的新辅助化疗方案（TIP 和 TP）对局部晚期鳞状细胞宫颈癌患者术后效果的比较方法是什么？\n\n<reference text>: A., et al.A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "在研究中比较两个不同的新辅助化疗方案（TIP 和 TP）对局部晚期鳞状细胞宫颈癌患者术后效果，通常采用随机对照试验的方法。具体而言，可以设立两个患者组，其中一个组接受三药联合方案（紫杉醇、异环膦酰胺和顺铂，即TIP方案），另一个组接受双药联合方案（紫杉醇和顺铂，即TP方案）。两组患者在接受化疗后，均进行根治性手术。通过对比两个组患者在手术后的疗效，例如病灶的缩小程度、病理完全缓解率、术后并发症发生率、生存率及无疾病进展时间等指标，可以评估两种方案相对的临床效果。这样的设计能够有效比较TIP和TP方案对局部晚期鳞状细胞宫颈癌术后效果的差异。"
}